Gallium-68-tilmanocept
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gallium-68-tilmanocept, covering 2023-12-01 to 2023-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer [Phase 3]